Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06750874 · ClinicalTrials.gov registry record · NA

Perioperative ACT for Preventing CPSP: a Single-arm Non-randomized Pilot Trial

A NA study of Back Pain and Spondylolisthesis, sponsored by Samantha Meints.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06750874 is a NA study of Back Pain and Spondylolisthesis that has completed, run by Samantha Meints. The registered enrollment target is 45 participants, below the 141-participant average among 37 other Back Pain trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06750874, a NA study of Back Pain and Spondylolisthesis, has completed, sponsored by Samantha Meints.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The present study aims to adapt and modify a brief perioperative Acceptance and Commitment Therapy (ACT) intervention aimed at preventing the transition to Chronic Post-Surgical Pain (CPSP) and reducing long-term opioid use. Investigators will assess the acceptability, feasibility, and preliminary efficacy of the intervention via a non-randomized, non-controlled pilot trial.

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Chestnut Hill

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2023-01-04
Est. Completion 2024-02-22
Phase NA

Sponsor

Samantha Meints

1 total trials

What the Registry Record Tells You About NCT06750874

The ClinicalTrials.gov registry entry for NCT06750874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 37 other Back Pain trials with a reported enrollment target (68% lower). The listed sponsor is Samantha Meints, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Acceptance and Commitment Therapy is the first listed.

NCT06750874 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06750874 about?

NCT06750874 is a clinical study titled "Perioperative ACT for Preventing CPSP: a Single-arm Non-randomized Pilot Trial". The present study aims to adapt and modify a brief perioperative Acceptance and Commitment Therapy (ACT) intervention aimed at preventing the transition to Chronic Post-Surgical Pain (CPSP) and reducing long-term opioid use. Investigators will assess the acceptability, feasibility, and preliminary e...

What is the current status of trial NCT06750874?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2023-01-04. Estimated completion is 2024-02-22.

What conditions does trial NCT06750874 study?

This clinical trial studies the following conditions: Back Pain, Spondylolisthesis, Spinal Stenosis, Spondylosis, Back Injury.

What interventions are being tested in trial NCT06750874?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06750874?

This trial is sponsored by Samantha Meints, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06750874 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.